Publications by Dr Brian Angus - ePrints

Browsing publications by Dr Brian Angus.

Newcastle Authors	Title	Year
Dr Michal Sieniawski Dr Brian Angus Professor Stephen Proctor Dr Anne Lennard	Impact of p53 positive p21 negative phenotype on outcome in CHOP-R treated DLBCL patients	2014
Dr Rachel Crossland Dr Michal Sieniawski Dr Brian Angus Professor Stephen Proctor Dr Paul Milne et al.	Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B-cell lymphoma patients	2013
Dr Rachel Crossland Dr Michal Sieniawski Dr Brian Angus Dr Susan Proctor Kate McCabe et al.	Mature microRNAs of the miR-17-92 cluster predict for disease outcome in diffuse large B-cell lymphoma (DLBCL) patients treated with CHOP-R immunochemotherapy	2011
Professor Mary Slatter Dr Brian Angus Dr Kevin Windebank Professor Sophie Hambleton Dr Mario Abinun et al.	Polymorphous lymphoproliferative disorder with Hodgkin-like features in common gamma-chain-deficient severe combined immunodeficiency	2011
Dr Rachel Crossland Dr John Anderson Dr Brian Angus Professor Stephen Proctor Dr Stephen Crosier et al.	A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines	2010
Dr Rachel Crossland Professor Stephen Proctor Dr Brian Angus Dr Stephen Crosier Dr John Anderson et al.	A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines	2010
Dr Rachel Crossland Dr John Anderson Dr Brian Angus Professor Stephen Proctor Dr Stephen Crosier et al.	A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines	2010
Dr John Anderson Lynne Overman Dr Katrina Wood Professor Stephen Proctor Dr Stephen Crosier et al.	Immunophenotyping of diffuse large B-cell lymphoma (DLBCL) defines multiple sub-groups of germinal centre-like tumours displaying different survival characteristics	2009
Dr Kevin Windebank Dr Brian Angus Dr Mario Abinun Dr Terence Flood Professor Andrew Cant et al.	Malignancy as a presentation of common gamma chain deficient severe combined immunodeficiency	2009
Dr Tryfonia Mainou-Fowler Lynne Overman Dr Katrina Wood Dr Brian Angus Professor Stephen Proctor et al.	A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2	2008
Dr Kevin Windebank Dr Brian Angus Dr Petra Dildey Dr Mario Abinun Dr Terence Flood et al.	Malignancy as a presentation of common gamma chain deficient severe combined immunodeficiency	2008
Seamus Kelly Dr John Anderson Dr Brian Angus Dr Christine Challen Professor John Lunec et al.	The predictive value of p53 and p33ING1b in patients with Dukes'C colorectal cancer	2008
Dr Tryfonia Mainou-Fowler Lynne Overman Dr Katrina Wood Dr Stephen Crosier Dr Brian Angus et al.	A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2	2007
Dr Brian Angus Dr Patrick Kesteven	Localized reactive angioendotheliomatosis	2007
Dr Penelope Taylor Dr Kevin Windebank Dr Helen Lucraft Dr Katrina Wood Dr Brian Angus et al.	Outcome of a risk-related therapeutic strategy used prospectively in a population-based study of Hodgkin's lymphoma in adolescents	2007
Dr Brian Angus Dr Penelope Taylor	Impact of tumor EBV status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma	2006
Dr Tryfonia Mainou-Fowler Dr Brian Angus Professor Stephen Proctor Dr Penelope Taylor Dr Katrina Wood et al.	Micro-vessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PdEGF) in classical Hodgkin lymphoma (HL)	2006
Dr Penelope Taylor Dr Brian Angus Professor Graham Jackson Dr Helen Lucraft Professor Stephen Proctor et al.	The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trial	2006
Dr Brian Angus Dr Andrew Carmichael	A case of Schopf-Schulz-Passarge syndrome	2005
Dr Brian Angus Dr Penelope Taylor	Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study	2005
Professor Stephen Proctor Dr Brian Angus Dr Katrina Wood Dr Tryfonia Mainou-Fowler	Microvessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PDEGF) in classical Hodgkin lymphoma (HL)	2005
Professor Andrew Gennery Dr Simon Harris Dr Brian Angus Professor Andrew Cant	Omenn's syndrome occurring in patients without mutations in recombination activating genes	2005
Dr John Anderson Dr Stephen Crosier Lynne Overman Dr Tryfonia Mainou-Fowler Dr Sarah Fordham et al.	Survivin in diffuse large B cell lymphoma: Evaluation as a prognostic marker	2005
Dr Brian Angus	An epidemiologic study of index and family infectious mononucleosis and adult Hodgkin's disease (HD): Evidence for a specific association with EBV+ve HD in young adults	2003
Dr John Anderson Dr Stephen Crosier Dr Jyotsna Shrimankar Professor John Lunec Dr Brian Angus et al.	Downregulation of nuclear expression of the p33^ING1binhibitor of growth protein in invasive carcinoma of the breast	2003
Dr Brian Angus Dr Clifford Lawrence	Histopathological assessment of tissue damage caused by electrodesiccation and fulguration	2003
Dr Stephen Crosier Dr Katrina Wood Dr Philip Taylor Professor Stephen Proctor Dr Brian Angus et al.	IAP survivin in diffuse large B cell lymphoma: Evaluation as a prognostic marker	2003
Dr Brian Angus Dr Gavin Spickett	Lymphoproliferative disease in antibody deficiency: a multi-centre study	2003
Professor Stephen Proctor Professor Graham Jackson Dr Anne Lennard Dr Brian Angus Dr Katrina Wood et al.	Strategic approach to the management of Hodgkin's disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK)	2003
Dr John Anderson Professor John Lunec Dr Brian Angus	The role of the tumour suppressor p33ING1b in human neoplasia	2003
Dr Brian Angus Dr Penelope Taylor	The Scotland and Newcastle epidemiological study of Hodgkin's disease: Impact of histopathological review and EBV status on incidence estimates	2003
Andrew Lodge Dr John Anderson Dr Beate Haugk Dr Brian Angus	Type 1 growth factor receptor expression in node positive breast cancer: Adverse prognostic significance of c-erbB-4	2003
Professor Muzlifah Haniffa Dr Brian Angus Dr Simon Meggitt	Warty granuloma faciale	2003
Professor Stephen Proctor Dr Brian Angus Professor Graham Jackson Dr Anne Lennard Dr Penelope Taylor et al.	A population-based study of intensive multi-agent chemotherapy with or without autotransplant for the highest risk Hodgkin's disease patients identified by the Scotland and Newcastle Lymphoma Group (SNLG) prognostic index. A Scotland and Newcastle Lymphoma Group study (SNLG HD III)	2002
Dr Brian Angus Professor John Lunec Dr Stephen Crosier Andrew Lodge Dr John Anderson et al.	Comparative assessment expression of the inhibitor of growth 1 gene (ING1) in normal and neoplastic tissues	2002
Dr Gail Stark Dr Katrina Wood Dr Fergus Jack Dr Brian Angus Professor Stephen Proctor et al.	Hodgkin's disease in the elderly: a population-based study	2002
Dr Fergus Jack Dr Brian Angus	Immunohistochemical detection of CD30 remains negative in nodular lymphocyte-predominant Hodgkin's disease using enhanced antigen retrieval	2002
Dr John Anderson Dr Katrina Wood Professor John Lunec Dr Andrew Hall Dr Michael Reid et al.	Loss of nuclear expression of the p33ING1b inhibitor of growth protein in childhood acute lymphoblastic leukaemia	2002
Dr John Anderson Dr Marie Mathers Dr Niamh Leonard Dr Stephen Crosier Professor John Lunec et al.	Nuclear to cytoplasmic compartment shift of the p33ING1b tumour suppressor protein is associated with malignancy in melanocytic lesions	2002
Seamus Kelly Dr John Anderson Dr Brian Angus Professor John Lunec	p33/ING1 nuclear expression and TP53 gene mutation in colorectal cancer and their association with clinical outcome	2002
Dr John Anderson Dr Stephen Crosier Dr Jyotsna Shrimankar Professor John Lunec Dr Brian Angus et al.	p33^ING1b tumour suppressor immunohistochemical expression in invasive breast carcinomas	2002
Seamus Kelly Dr John Anderson Dr Brian Angus Professor John Lunec	TP53 and p33(Ing1) are co-determinants of prognosis in colorectal cancer	2002
Dr Stephen Crosier Dr Brian Angus Dr John Anderson	Use of transgenomic wave and denaturing gel electrophoresis increases the sensitivity of FR3A-FR4 PCR detection of B-cell clonality	2002
Dr Brian Angus Professor David Neal Professor John Lunec Kilian Mellon	Cyclin D1 expression in transitional cell carcinoma of the bladder: Correlation with p53, waf1, pRb and Ki67	2001
Professor John Lunec Seamus Kelly Dr John Anderson Dr Brian Angus	Expression of p33/ING1 gene products in colorectal cancer and its correlation with survival	2001
Dr John Anderson Professor John Lunec Dr Andrew Hall Dr Michael Reid Dr Brian Angus et al.	p33(ING1b) tumour suppresser protein expression in childhood acute lymphoblastic leukaemia by immunohistochemistry	2001
Dr Stephen Crosier Dr John Anderson Dr Marie Mathers Dr Niamh Leonard Dr Stephen Crosier et al.	p33(ING1b) tumour suppresser protein expression in melanocytic lesions, an immunohistochemical study of 67 cases	2001
Seamus Kelly Professor John Lunec Dr John Anderson Dr Brian Angus	p33/ING1 nuclear expression in colorectal cancer and its correlation with metastasis and survival	2001
Dr John Anderson Dr Stephen Crosier Professor John Lunec Dr Brian Angus	p33^ING1b tumour suppresser protein expression in thyroid lesions determined by immunohistochemistry	2001
Dr Marie Mathers Dr Jyotsna Shrimankar Dr David Scott Dr Fraser Charlton Clive Griffith et al.	The use of a standard proforma in breast cancer reporting	2001
Dr Claire Bethune Dr Brian Angus Dr Gavin Spickett	Treatment of EBV driven lymphoproliferation with erythrophagocytosis: 12 year follow up	2001
Dr Brian Angus Professor Andrew Cant	Cytomegalovirus infection in infants with autoimmune lymphoproliferative syndrome (ALPS)	2000
Andrew Lodge Dr John Anderson Dr Beate Haugk Dr Brian Angus	Expression of topoisomerase III alpha in normal and neoplastic tissues determined by immunohistochemistry using a novel monoclonal antibody	2000
Andrew Lodge Dr John Anderson Dr Beate Haugk Dr Brian Angus	Expression of topoisomerase IIIα in normal and neoplastic tissues determined by immunohistochemistry using a novel monoclonal antibody	2000
Dr Brian Angus Dr Fergus Jack Professor Graham Jackson Professor Stephen Proctor Dr Penelope Taylor et al.	Improved estimation of tumour burden leads to better prognostic discrimination in classical hodgkin's disease in adults	2000
Dr Brian Angus Dr Bridget Wilkins	Molecular analysis reveals somatically mutated and unmutated clonal and oligoclonal B cells in T-cell-rich B-cell lymphoma	2000
Dr Brian Angus Professor John Lunec Dr John Anderson	Monoclonal antibodies raised to products of the ING1 tumour suppressor gene locus.	2000
Andrew Lodge Dr John Anderson Dr Brian Angus	Pixel-based image cytometry for quantification of nuclear antigen expression using Adobe Photoshop	2000
Dr John Anderson Dr Brian Angus Professor John Lunec	Sequencing of ING1 tumour suppressor gene cDNAs generated from mRNA recovered from normal and neoplastic cell lines.	2000
Andrew Lodge Dr John Anderson Dr Beate Haugk Dr Brian Angus	Type 1 growth factor receptor and topoisomerase expression in breast cancer: Adverse prognostic significance of c-erbB-4	2000
Dr Brian Angus Dr Sathyarathna Gokul Professor Alan Calvert Professor John Lunec	Bcl-2 expression is a potential prognostic co-factor with P53- mutation status in epithelial ovarian carcinoma	1999
Dr Debbie Scott Dr Brian Angus	Cyclin D1 expression in usual hyperplasia, atypical ductal hyperplasia and low nuclear grade ductal carcinoma in situ of the breast: an immunohistochemical study	1999
Dr Ian Brotherick Dr Brian Shenton Dr Brian Angus Jagnohan Varma Professor Frederick Campbell et al.	Cyclin D3 expression, cell proliferation and pathological stage of human primary colorectal cancer	1999
Dr Craig Dixon Dr Simon Sinclair Dr Fraser Charlton Dr John Anderson Professor Peter Farr et al.	Diagnosis of mycosis fungoides using histological evaluation, immunophenotyping and molecular analysis in formalin-fixed, parafin-embedded tissue	1999
Abid Sattar Professor Steve Robson Dr Brian Angus Professor Frederick Campbell	Expression of growth regulatory genes in a SCID mouse-human model of intestinal epithelial regeneration	1999
Andrew Lodge Dr Andrew Hall Dr Katrina Wood Dr John Anderson Dr Brian Angus et al.	NCL-CD10-270: A new monoclonal antibody recognizing CD10 in paraffin- embedded tissue	1999
Dr Fergus Jack Dr Brian Angus Dr Penelope Taylor	Prognostic score for Hodgkin's disease	1999
Dr Fergus Jack Dr Brian Angus	Signal amplification using biotinylated tyramide for detection of CD 30 and epithelial membrane antigen in nodular lymphocyte predominant Hodgkin's disease	1999
Helen Bell Dr Brian Angus	The value of BCL-6 expression in the differential diagnosis of small B cell lymphoma.	1999
Andrew Lodge Dr Andrew Hall Dr John Anderson Dr Michael Reid Dr Brian Angus et al.	A study of the prognostic significance of topoisomerase IIα in childhood acute lymphoblastic Leukaemia	1998
Professor Stephen Proctor Dr Penelope Taylor Dr Brian Angus	A prospective evaluation of the use of a numerical prognostic index for patient management in the context of a population-adjusted clinical epidemiology (PACE) study in the Northern Region, UK	1998
Dr Brian Angus Professor David Neal Professor John Lunec Kilian Mellon	Cyclin Dl expression in TCC of the bladder: Correlation with WAF1, p53 and Ki67	1998
Dr John Anderson Dr William Cowan William Cunliffe Dr Brian Angus	ER-CARD: a more sensitive method for detection of oestrogen receptor by immunohistochemistry	1998
Professor Julie Irving Gerard Cain Dr Brian Angus Dr Penelope Taylor	The role of alternative splicing of the adhesion molecule, CD44, in lymphoid malignancy	1998
Dr John Anderson Professor Thomas Lennard Dr Brian Angus	A novel quantitative immunoassay system for p53 using antibodies selected for optimum designation of p53 status	1997
Professor Graham Jackson Dr Philip Taylor Dr David Goff Dr Anne Lennard Dr Brian Angus et al.	High dose ifosfamide in combination with etoposide and epirubicin in the treatment of relapsed/refactory Hodgkin's disease: A report on toxicity and efficacy.	1997
Professor Debra Bevitt Emeritus Professor Geoffrey Toms Professor Thomas Lennard Professor Bruce Westley Dr Brian Angus et al.	New monoclonal antibodies to oestrogen and progesterone receptors effective for paraffin section immunohistochemistry	1997
Dr Mark Egan Dr John Anderson Dr William Cowan Dr Brian Angus	Optimised determination of vascular invasion in breast cancer by immunohistochemistry for CD31: production of a novel monoclonal antibody and comparison with conventional assessment.	1997
Professor Nick Reynolds Carole Todd Dr Brian Angus	Overexpression of protein kinase C-α and -β isozymes by stromal dendritic cells in basal and squamous cell carcinoma	1997
Alan Adams Dr Brian Angus Dr Gajanan Sherbet Professor Thomas Lennard	Prediction of nodal metastasis and prognosis in breast cancer: A neural model	1997
Professor Julie Irving Gerard Cain Dr Brian Angus	The role of alternative splicing of the adhesion molecule, CD44 in lymphoid malignancy	1997
Dr John Anderson Dr Brian Angus	Determination of the clinical significance of cyclin a expression in human breast cancer using a novel monoclonal antibody	1996
Professor Julie Irving Gerard Cain Dr Brian Angus	OCT embedded sections of pathological specimens as a source of high quality RNA for reverse transcriptase/polymerase chain reaction	1996
Dr John Anderson Dr Brian Angus Professor Thomas Lennard	p53 protein as a prognostic indicator in breast carcinoma: A comparison of four antibodies for immunohistochemistry	1996
Dr John Anderson Professor Thomas Lennard Dr Brian Angus	Retinoblastoma protein in human breast carcinoma: Immunohistochemical study using a new monoclonal antibody effective on routinely processed tissues	1996
Alan Adams Dr Brian Angus Dr Gajanan Sherbet Professor Thomas Lennard	The detection of nodal metastasis in breast cancer using neural network techniques	1996
Dr Mark Levasseur Dr Peter Middleton Dr Brian Angus Professor Stephen Proctor Jean Norden et al.	c-MYC gene abnormalities in high grade and centroblastic-centrocytic Non-Hodgkins Lymphoma	1995
Dr John Anderson Dr Brian Angus Professor Thomas Lennard	Determination of the prognostic value of cyclin D1 overexpression in breast cancer	1995
Dr Ian Brotherick Dr Brian Shenton Dr William Cowan Dr Brian Angus Professor Thomas Lennard et al.	P53 expression measured by flow cytometry: a comparison of 3 monoclonal antibodies and the relationship with grade and DNA ploidy in breast cancer	1995
Dr Ian Brotherick Dr Brian Shenton Dr Brian Angus Ian Waite Professor Thomas Lennard et al.	A flow cytometric study of c-erbB-3 expression in breast cancer	1995
Dr Ian Brotherick Dr Brian Shenton Dr William Cowan Dr Brian Angus Professor Thomas Lennard et al.	Relationship between flow cytometric and immunohistochemically detected C-ERBB-2 expression, grade and DNA ploidy in breast cancer	1995
Dr Anne Lennard Dr Brian Angus Professor Stephen Proctor	Prognostic Significance of Epstein Barr Virus Association in Hodgkins Disease	1994
Professor Graham Jackson Dr Anne Lennard Dr Penelope Taylor Dr Peter Carey Dr Brian Angus et al.	Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission	1994
Dr John Anderson Dr Christopher Wright Dr Brian Angus	NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohistochemical study	1994
Dr Penelope Taylor Professor Graham Jackson Dr Anne Lennard Dr Helen Lucraft Professor Stephen Proctor et al.	Autologous transplantation in poor risk Hodgkin's disease using high dose melphalan/etoposide conditioning with non-cryopreserved marrow rescue	1993
Dr Brian Angus Dr Christopher Wright Professor Thomas Lennard Dr Ian Corbett	Retinoblastoma and P53 gene expression related to relapse and survival in human breast cancer - an immunohistochemical study	1992
Dr Felicity May Professor Bruce Westley Dr Brian Angus Professor Thomas Lennard	Expression of antimetastatic gene NM23	1991
Dr Felicity May Professor Bruce Westley Dr Brian Angus Professor Thomas Lennard	Expression of the antimetastatic gene NM23 in human breast cancer: an association with good prognosis	1991
Professor Thomas Lennard Dr Brian Angus	P53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study	1991
Dr Brian Angus Diana Levett Dr Sarah Johnson Professor Thomas Lennard Dr Felicity May et al.	The prognostic significance of the lysosomal protease cathepsin-D in human breast cancer - an immunohistochemical study	1991
Dr Roger Dykins Dr Ian Corbett Dr Christopher Wright Professor Thomas Lennard Dr Brian Angus et al.	Long-term survival in breast cancer related to overexpression of the C-ERBB-1 oncoprotein - an immunohistochemical study using monoclonal antibody NCL-CB11	1991
Dr Brian Angus Professor Bruce Westley Dr Felicity May	Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study.	1990
Dr Christopher Wright Dr Ian Corbett Dr Brian Angus Professor Thomas Lennard	C-ERBB-2 oncoprotein expression in mammary and extramammary pagets disease - an immunohistochemical study	1990
Craig Wright Dr Ian Corbett Professor Thomas Lennard Dr Brian Angus	C-ERBB-2 Oncoprotein expression in mammary and extramammary pagets disease determined by immunohistochemistry using the novel monoclonal antibody NCL-CB11	1990
Dr Ian Corbett Dr Brian Angus Dr Felicity May Professor Bruce Westley	NCL-CB11 anto c-erbb-2 monoclonal antibody characterization and correlation with gene amplification	1990
Dr Ian Corbett Dr Brian Angus Dr Felicity May Professor Bruce Westley	NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbb-2 oncogene protein effective for use on formalin fixed, paraffin embedded tissue	1990
Dr Felicity May Professor Bruce Westley Dr Brian Angus Professor Thomas Lennard	The antimetastatic gene NM23: its expression in human breast cancers	1990
Dr Ian Corbett Dr Christopher Wright Professor Thomas Lennard Dr Brian Angus	c-erbB-2 oncoprotein expression related to hitological type in breast cancer: an immunohistochemical study.	1990
Dr Brian Angus Dr Andrew Hall Professor Stephen Proctor	Glutathione S-transferase (placental) as a marker of transformation in the human cervix uteri: an immunohistochemical study	1990
Dr Anne Lennard Professor Stephen Proctor Dr Brian Angus Dr Helen Lucraft	Lomustine, vindesine and bleomycin (LVB) used in the treatment of relapsed advanced Hodgkin's disease: A prospective study on behalf of the east of Scotland and Newcastle lymphoma group (ESNLG)	1989
Dr Mary Robinson Dr Brian Angus Professor Stephen Proctor	Lymphocyte depleted Hodgkins disease: A retrospective immunohistological study	1987